 | • レポートコード：MRC2302D037 • 出版社/出版日：Transparency Market Research / 2022年12月5日 • レポート形態：英語、PDF、121ページ • 納品方法：Eメール（受注後24時間以内） • 産業分類：医療機器 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の市場調査レポートは、2022年に108億ドルであった世界の心臓埋め込み型電子機器市場規模が2031年には161億ドルとなり、予測期間の間に年平均3.6％増加すると展望しています。当レポートでは、心臓埋め込み型電子機器の世界市場を調査対象とし、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場展望、製品別（ペースメーカー、植込み型除細動器、植込み型心電ループレコーダー）分析、用途別（不整脈、心拍数モニタリング、心臓ブロック/心不全、その他）分析、エンドユーザー別（病院、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競合状況などの項目をまとめました。並びに、当レポートに記載されている企業情報には、Abbott、Medtronic plc、Boston Scientific Corporation、Biotronic AG、Angel Medical Systems, Inc.、MicroPort、Cook Medical, Inc.、Lepu Medical Technology(Beijing) Co., Ltd.、Vitatron、MEDICO S.R.L.などが含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場展望 ・世界の心臓埋め込み型電子機器市場規模：製品別 - ペースメーカーの市場規模 - 植込み型除細動器の市場規模 - 植込み型心電ループレコーダーの市場規模 ・世界の心臓埋め込み型電子機器市場規模：用途別 - 不整脈における市場規模 - 心拍数モニタリングにおける市場規模 - 心臓ブロック/心不全における市場規模 - その他用途における市場規模 ・世界の心臓埋め込み型電子機器市場規模：エンドユーザー別 - 病院における市場規模 - 外来手術センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の心臓埋め込み型電子機器市場規模：地域別 - 北米の心臓埋め込み型電子機器市場規模 - ヨーロッパの心臓埋め込み型電子機器市場規模 - アジア太平洋の心臓埋め込み型電子機器市場規模 - 中南米の心臓埋め込み型電子機器市場規模 - 中東・アフリカの心臓埋め込み型電子機器市場規模 ・競合状況 |
Cardiac Implantable Electronic Device Market – Scope of Report
TMR’s report on the global cardiac implantable electronic device market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global cardiac implantable electronic device market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cardiac implantable electronic device market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the cardiac implantable electronic device market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cardiac implantable electronic device market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global cardiac implantable electronic device market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cardiac implantable electronic device market.
The report delves into the competitive landscape of the global cardiac implantable electronic device market. Key players operating in the global cardiac implantable electronic device market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global cardiac implantable electronic device market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market cardiac implantable electronic device.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cardiac Implantable Electronic Device Market
4. Market Overview
4.1. Introduction
4.1.1. Product Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, 2017–2031
4.3.1. Global Cardiac Implantable Electronic Device Market Revenue Projection (US$ Mn)
5. Market Outlook
5.1. Technological Advancement
5.2. Cardiovascular Disease Prevalence
5.3. Value Chain Analysis
5.4. COVID-19 Impact Analysis
6. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, by Product
6.1. Key Findings/Developments
6.2. Introduction & Definition
6.3. Global Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031
6.3.1. Pacemakers
6.3.1.1. Single-chamber
6.3.1.2. Dual-chamber
6.3.1.3. Biventricular
6.3.2. Implantable Cardioverter Defibrillator
6.3.2.1. Transvenous ICD
6.3.2.2. Subcutaneous ICD
6.3.3. Implantable Cardiac Loop Recorders
6.4. Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product
7. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, by Application
7.1. Key Findings/Developments
7.2. Introduction & Definition
7.3. Global Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031
7.3.1. Arrhythmia
7.3.2. Heart Rhythm Monitoring
7.3.3. Heart Block/Failure
7.3.4. Others
7.4. Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application
8. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, by End-user
8.1. Key Findings/Developments
8.2. Introduction & Definition
8.3. Global Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user
9. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, by Region
9.1. Geographical Representation
9.2. Global Cardiac Implantable Electronic Device Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Region
10. North America Cardiac Implantable Electronic Device Market Analysis and Forecast
10.1. North America Cardiac Implantable Electronic Device Market Value Share Analysis, by Country, 2017–2031
10.2. North America Cardiac Implantable Electronic Device Market Value Forecast, by Country, 2017–2031
10.2.1. U.S.
10.2.2. Canada
10.3. North America Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031
10.4. North America Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031
10.4.1. Pacemakers
10.4.1.1. Single-chamber
10.4.1.2. Dual-chamber
10.4.1.3. Biventricular
10.4.2. Implantable Cardioverter Defibrillators
10.4.2.1. Transvenous ICD
10.4.2.2. Subcutaneous ICD
10.4.3. Implantable Cardiac Loop Recorders
10.5. North America Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031
10.6. North America Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031
10.6.1. Arrhythmia
10.6.2. Heart Rhythm Monitoring
10.6.3. Heart Block/Failure
10.6.4. Others
10.7. North America Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031
10.8. North America Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031
10.8.1. Hospitals
10.8.2. Ambulatory Surgical Centers
10.8.3. Others
10.9. North America Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)
10.9.1. By Country
10.9.2. By Product
10.9.3. By Application
10.9.4. By End-user
11. Europe Cardiac Implantable Electronic Device Market Analysis and Forecast
11.1. Europe Cardiac Implantable Electronic Device Market Value Forecast, by Country/Sub-region, 2017–2031
11.1.1. Germany
11.1.2. France
11.1.3. U.K.
11.1.4. Spain
11.1.5. Italy
11.1.6. Rest of Europe
11.2. Europe Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031
11.3. Europe Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031
11.3.1. Pacemakers
11.3.1.1. Single-chamber
11.3.1.2. Dual-chamber
11.3.1.3. Biventricular
11.3.2. Implantable Cardioverter Defibrillators
11.3.2.1. Transvenous ICD
11.3.2.2. Subcutaneous ICD
11.3.3. Implantable Cardiac Loop Recorders
11.4. Europe Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031
11.5. Europe Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031
11.5.1. Arrhythmia
11.5.2. Heart Rhythm Monitoring
11.5.3. Heart Block/Failure
11.5.4. Others
11.6. Europe Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031
11.7. Europe Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031
11.7.1. Hospitals
11.7.2. Ambulatory Surgical Centers
11.7.3. Others
11.8. Europe Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)
11.8.1. By Country/Sub-region
11.8.2. By Product
11.8.3. By Application
11.8.4. By End-user
12. Asia Pacific Cardiac Implantable Electronic Device Market Analysis and Forecast
12.1. Asia Pacific Cardiac Implantable Electronic Device Market Value Forecast, by Country/Sub-region, 2017–2031
12.1.1. China
12.1.2. Japan
12.1.3. India
12.1.4. Australia & New Zealand
12.1.5. Rest of Asia Pacific
12.2. Asia Pacific Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031
12.3. Asia Pacific Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031
12.3.1. Pacemakers
12.3.1.1. Single-chamber
12.3.1.2. Dual-chamber
12.3.1.3. Biventricular
12.3.2. Implantable Cardioverter Defibrillators
12.3.2.1. Transvenous ICD
12.3.2.2. Subcutaneous ICD
12.3.3. Implantable Cardiac Loop Recorders
12.4. Asia Pacific Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031
12.5. Asia Pacific Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031
12.5.1. Arrhythmia
12.5.2. Heart Rhythm Monitoring
12.5.3. Heart Block/Failure
12.5.4. Others
12.6. Asia Pacific Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031
12.7. Asia Pacific Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031
12.7.1. Hospitals
12.7.2. Ambulatory Surgical Centers
12.7.3. Others
12.8. Asia Pacific Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)
12.8.1. By Country/Sub-region
12.8.2. By Product
12.8.3. By Application
12.8.4. By End-user
13. Latin America Cardiac Implantable Electronic Device Market Analysis and Forecast
13.1. Latin America Cardiac Implantable Electronic Device Market Value Forecast, by Country/Sub-region, 2017-2027
13.1.1. Brazil
13.1.2. Mexico
13.1.3. Rest of Latin America
13.2. Latin America Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031
13.3. Latin America Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031
13.3.1. Pacemakers
13.3.1.1. Single-chamber
13.3.1.2. Dual-chamber
13.3.1.3. Biventricular
13.3.2. Implantable Cardioverter Defibrillators
13.3.2.1. Transvenous ICD
13.3.2.2. Subcutaneous ICD
13.3.3. Implantable Cardiac Loop Recorders
13.4. Latin America Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031
13.5. Latin America Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031
13.5.1. Arrhythmia
13.5.2. Heart Rhythm Monitoring
13.5.3. Heart Block/Failure
13.5.4. Others
13.6. Latin America Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031
13.7. Latin America Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031
13.7.1. Hospitals
13.7.2. Ambulatory Surgical Centers
13.7.3. Others
13.8. Latin America Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)
13.8.1. By Country/Sub-region
13.8.2. By Product
13.8.3. By Application
13.8.4. By End-user
14. Middle East & Africa Cardiac Implantable Electronic Device Market Analysis and Forecast
14.1. Middle East & Africa Cardiac Implantable Electronic Device Market Value Forecast, by Country/Sub-region, 2017–2031
14.1.1. GCC Countries
14.1.2. South Africa
14.1.3. Rest of Middle East & Africa
14.2. Middle East & Africa Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031
14.3. Middle East & Africa Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031
14.3.1. Pacemakers
14.3.1.1. Single-chamber
14.3.1.2. Dual-chamber
14.3.1.3. Biventricular
14.3.2. Implantable Cardioverter Defibrillators
14.3.2.1. Transvenous ICD
14.3.2.2. Subcutaneous ICD
14.3.3. Implantable Cardiac Loop Recorders
14.4. Middle East & Africa Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031
14.5. Middle East & Africa Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031
14.5.1. Arrhythmia
14.5.2. Heart Rhythm Monitoring
14.5.3. Heart Block/Failure
14.5.4. Others
14.6. Middle East & Africa Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031
14.7. Middle East & Africa Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031
14.7.1. Hospitals
14.7.2. Ambulatory Surgical Centers
14.7.3. Others
14.8. Middle East & Africa Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)
14.8.1. By Country/Sub-region
14.8.2. By Product
14.8.3. By Application
14.8.4. By End-user
15. Competition Landscape
15.1. Competition Matrix
15.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
15.2.1. Medtronic plc (HQ, Business Segments, Employee Strength)
15.2.1.1. Company Details
15.2.1.2. Company Description
15.2.1.3. Business Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Financial Analysis
15.2.1.6. Strategic Overview
15.2.2. Biotronic AG (HQ, Business Segments, Employee Strength)
15.2.2.1. Company Details
15.2.2.2. Company Description
15.2.2.3. Business Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. Abbott Laboratories (HQ, Business Segments, Employee Strength)
15.2.3.1. Company Details
15.2.3.2. Company Description
15.2.3.3. Business Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. Angel Medical Systems, Inc. (HQ, Business Segments, Employee Strength)
15.2.4.1. Company Details
15.2.4.2. Company Description
15.2.4.3. Business Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. Boston Scientific Corporation (HQ, Business Segments, Employee Strength)
15.2.5.1. Company Details
15.2.5.2. Company Description
15.2.5.3. Business Overview
15.2.5.4. SWOT Analysis
15.2.5.5. Financial Analysis
15.2.5.6. Strategic Overview
15.2.6. MicroPort (HQ, Business Segments, Employee Strength)
15.2.6.1. Company Details
15.2.6.2. Company Description
15.2.6.3. Business Overview
15.2.6.4. SWOT Analysis
15.2.6.5. Financial Analysis
15.2.6.6. Strategic Overview
15.2.7. Lepu Medical Technology (Beijing) Co., Ltd. (HQ, Business Segments, Employee Strength)
15.2.7.1. Company Details
15.2.7.2. Company Description
15.2.7.3. Business Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Financial Analysis
15.2.7.6. Strategic Overview
15.2.8. MEDICO S.R.L. (HQ, Business Segments, Employee Strength)
15.2.8.1. Company Details
15.2.8.2. Company Description
15.2.8.3. Business Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Financial Analysis
15.2.8.6. Strategic Overview
15.2.9. Vitatron (HQ, Business Segments, Employee Strength)
15.2.9.1. Company Details
15.2.9.2. Company Description
15.2.9.3. Business Overview
15.2.9.4. SWOT Analysis
15.2.9.5. Financial Analysis
15.2.9.6. Strategic Overview
15.2.10. Cook Medical Inc. (HQ, Business Segments, Employee Strength)
15.2.10.1. Company Details
15.2.10.2. Company Description
15.2.10.3. Business Overview
15.2.10.4. SWOT Analysis
15.2.10.5. Financial Analysis
15.2.10.6. Strategic Overview